15,472 reports of this reaction
11.9% of all EXENATIDE reports
#1 most reported adverse reaction
BLOOD GLUCOSE INCREASED is the #1 most commonly reported adverse reaction for EXENATIDE, manufactured by AstraZeneca Pharmaceuticals LP. There are 15,472 FDA adverse event reports linking EXENATIDE to BLOOD GLUCOSE INCREASED. This represents approximately 11.9% of all 130,422 adverse event reports for this drug.
Patients taking EXENATIDE who experience blood glucose increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD GLUCOSE INCREASED is a frequently reported adverse event for EXENATIDE, accounting for a significant proportion of all reports.
In addition to blood glucose increased, the following adverse reactions have been reported for EXENATIDE:
The following drugs have also been linked to blood glucose increased in FDA adverse event reports:
BLOOD GLUCOSE INCREASED has been reported as an adverse event in 15,472 FDA reports for EXENATIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD GLUCOSE INCREASED accounts for approximately 11.9% of all adverse event reports for EXENATIDE, making it one of the most commonly reported side effect.
If you experience blood glucose increased while taking EXENATIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.